B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PPP2CA

MOLECULAR TARGET

protein phosphatase 2 catalytic subunit alpha

UniProt: P67775NCBI Gene: 55153 compounds

PPP2CA (protein phosphatase 2 catalytic subunit alpha) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PPP2CA

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1cantharidin3.1823
2calyculin a2.208
3Okadaic Acid0.691

About PPP2CA as a Drug Target

PPP2CA (protein phosphatase 2 catalytic subunit alpha) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented PPP2CA interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PPP2CA inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.